Clinical Trials Browser

Terminated × Hemangiosarcoma × Paclitaxel × Clear all

NCT02212015 2022-03-22

EVA

Phase 2 Terminated

26 enrolled 16 charts

Hemangiosarcoma

NCT01055028 2018-03-26

Paclitaxel + Bevacizumab (Avastin) for the Treatment of Metastatic or Unresectable Angiosarcoma

Phase 2 Terminated

18 enrolled 13 charts

Hemangiosarcoma, Sarcoma